Isoxyl

Isoxyl (Thiocarlide; 4,4'-diisoamyloxydiphenylthiourea) is a thiourea chemical that was used in the 1960s to successfully treat tuberculosis (TB). It has considerable antimycobacterial activity in vitro and is effective against multi-drug resistant strains of Mycobacterium tuberculosis. Isoxyl inhibits M. bovis with six hours of exposure, which is similar to isoniazid and ethionamide, two other prominent anti-TB drugs. Unlike these two drugs, however, isoxyl also partially inhibits the synthesis of fatty acids.

Additional recommended knowledge

Don't let static charges disrupt your weighing accuracy

Daily Visual Balance Check

Daily Sensitivity Test

Isoxyl was developed by a Belgian company, Continental Pharma S.A. Belgo-Canadienne in Brussels, Belgium. The head researcher was Professor N. P. Buu-Hoi, head of Continental Pharma's Research Division.